4.7 Article

A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells

期刊

CHEMICAL COMMUNICATIONS
卷 49, 期 67, 页码 7442-7444

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c3cc44508a

关键词

-

资金

  1. Health Labour Sciences Research Grant (Research on Publicly Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare of Japan
  2. Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [21300190, 23650288]
  3. MEXT [23800045]
  4. Grants-in-Aid for Scientific Research [23650288, 23800045, 25870392, 21300190] Funding Source: KAKEN

向作者/读者索取更多资源

Herein, we report the preparation of genetically engineered protein cages (HspG41C-SP94), taken up selectively by human hepatocellular carcinoma (HCC) cells. An engineered protein cage-doxorubicin (DOX) conjugate was as cytotoxic as free DOX against HCC cells but much less cytotoxic against normal hepatocytes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据